相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives
Bin Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Novel 9a-carbamoyl- and 9a-thiocarbamoyl-3-decladinosyl-6-hydroxy and 6-methoxy derivatives of 15-membered macrolides
Zorica Marusic Istuk et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
Akshay Gupta et al.
AMERICAN HEART JOURNAL (2007)
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3
Annick Seithel et al.
DRUG METABOLISM AND DISPOSITION (2007)
Preparation of cyclic 2′,3′-carbamate derivatives of erythromycin macrolide antibiotics
Audun Heggelund et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Ketek - The FDA perspective
Janice Soreth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries
Herman Goossens et al.
CLINICAL INFECTIOUS DISEASES (2007)
Resistance phenotypes conferred by macrolide phosphotransferases
Olivier Chesneau et al.
FEMS MICROBIOLOGY LETTERS (2007)
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae
Nicole Wolter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US study
David J. Farrell et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Myasthenia gravis exacerbation or unmasking associated with telithromycin treatment
X. Perrot et al.
NEUROLOGY (2006)
Synthesis and antibacterial activity of C6-carbazate ketolides
Manomi A. Tennakoon et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
23S rRNA 2058A→G alteration mediates ketolide resistance in combination with deletion in L22
Rita Berisio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe
Adnan Al-Lahham et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Macrolide and ketolide resistance with Streptococcus pneumoniae
Gary V. Doern
MEDICAL CLINICS OF NORTH AMERICA (2006)
Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model
E. Azoulay-Dupuis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Synthesis and antibacterial activity of novel C12 ethyl ketolides
Matthew T. Burger et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Medication use for pediatric upper respiratory tract infections
Biswadeep Das et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2006)
European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe
Samuel Coenen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether:: Synthesis and structure-activity relationships (2)
T Nomura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
EDP-420.: Ketolide antibiotic.
P. Revill et al.
DRUGS OF THE FUTURE (2006)
Telithromycin-induced digoxin toxicity and electrocardiographic changes
Laura M. Nenciu et al.
PHARMACOTHERAPY (2006)
Streptococcus pneumoniae isolates resistant to telithromycin
M Rantala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The effect of telithromycin in acute exacerbations of asthma
SL Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Synthesis and antibacterial activity of 6-O-heteroarylcarbamoyl-11,12-lactoketolides
EB Grant et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia
C Carbon et al.
RESPIRATORY MEDICINE (2006)
Effect of telithromycin and azithromycin on nasopharyngeal bacterial flora in patients with acute maxillary sinusitis
I Brook et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Brief communication: Severe hepatotoxicity of telithromycin: Three case reports and literature review
KD Clay et al.
ANNALS OF INTERNAL MEDICINE (2006)
Synthesis and antibacterial activity of novel C12 vinyl ketolides
MT Burger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae
T Bogdanovich et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages
M Barcia-Macay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Telithromycin, but not montelukast, increases the plasma concentrations and effects of the cytochrome P450 3A4 and 2C8 substrate repaglinide
LI Kajosaari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
In vitro activity of telithromycin against Gram-negative bacterial pathogens
D Felmingham et al.
JOURNAL OF INFECTION (2006)
Synthesis and antibacterial activity of 3-O-acyl-6-O-carbamoyl erythromycin A derivatives
B Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations
DJ Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Acute bacterial rhinosinusitis: A review of US treatment guidelines
Bradley F. Marple et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2006)
Involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in telithromycin transport
S Yamaguchi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: Phenotypic and genotypic analysis
IN Grivea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure-activity relationships
T Nomura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Species-specific antibiotic-ribosome interactions:: implications for drug development
DN Wilson et al.
BIOLOGICAL CHEMISTRY (2005)
Guidelines for the management of adult lower respiratory tract infections
M Woodhead et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Resistance to telithromycin is conferred by msr(A), msrC and msr(D) in Staphylococcus aureus
ED Reynolds et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
9-Oxime-3-ketolides: Modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens
T Nomura et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
ABC proteins and antibiotic drug resistance: is it all about transport?
ID Kerr et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization
C Fogarty et al.
CHEST (2005)
The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae
DJ Farrell et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Ketolide resistance in Streptococcus pyogenes correlates with the degree of rRNA dimethylation by Erm
S Douthwaite et al.
MOLECULAR MICROBIOLOGY (2005)
Pharmacokinetics of telithromycin: application to dosing in the treatment of community-acquired respiratory tract infections
CA Ciervo et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany
RR Reinert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Current management of acute bacterial rhinosinusitis and the role of moxifloxacin
JB Anon
CLINICAL INFECTIOUS DISEASES (2005)
Telithromycin: A ketolide antibiotic for treatment of respiratory tract infections
JR Lonks et al.
CLINICAL INFECTIOUS DISEASES (2005)
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin
M Bosnar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study
CM Fogarty et al.
BMC INFECTIOUS DISEASES (2005)
Pharmacodynamic activity of telithromycin at simulated clinically achievable free-drug concentrations in serum and epithelial lining fluid against efflux (mefE)-producing macrolide-resistant Streptococcus pneumoniae for which telithromycin MICs vary
GG Zhanel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens
TP Lodise et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance
D Tu et al.
CELL (2005)
Quinolones in 2005: an update
F Van Bambeke et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing
JE Stout et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis: a pooled analysis
K Roos et al.
JOURNAL OF INFECTION (2005)
Penetration of telithromycin into the nasal mucosa and ethmoid bone of patients undergoing rhinosurgery for chronic sinusitis
TS Kuehnel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Telithromycin activity is reduced by efflux in Streptococcus pyogenes
R Cantón et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Verapamil toxicity resulting from a probable interaction with telithromycin
M Reed et al.
ANNALS OF PHARMACOTHERAPY (2005)
Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumonia
J Shi et al.
CLINICAL PHARMACOKINETICS (2005)
Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial
J Shi et al.
CLINICAL PHARMACOKINETICS (2005)
Macrolides in the treatment of asthma and cystic fibrosis
G Ferrara et al.
RESPIRATORY MEDICINE (2005)
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
GW Amsden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Mechanisms of resistance to telithromycin in Streptococcus pneumoniae
T Hisanaga et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Pharmacodynamic profile of telithromycin against macrolide- and fluoroquinolone-resistant Streptococcus pneumoniae in a neutropenic mouse thigh model
PR Tessier et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
In vitro activities of novel 2-fluoro-naphthyridine-containing ketolides
D Abbanat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro
MT Labro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae
JH Jorgensen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Synthesis and antibacterial activity of C-6 carbamate ketolides, a novel series of orally active ketolide antibiotics
TC Henninger et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Efficacy and safety of oral telithromycin once daily for 5 days versus moxifloxacin once daily for 10 days in the treatment of acute bacterial rhinosinusitis
BJ Ferguson et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2004)
Steady-state plasma and intrapulmonary pharmacokinetics and pharmacodynamics of cethromycin
JE Conte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia
G Tellier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis
SR Norrby et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Efficacy and tolerability of once-daily oral telithromycin compared with clarithromycin for the treatment of community-acquired pneumonia in adults
LM Dunbar et al.
CLINICAL THERAPEUTICS (2004)
High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae
F Walsh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Intracellular pharmacodynamics of antibiotics
S Carryn et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia
C Carbon et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Structural insight into the antibiotic action of telithromycin against resistant mutants
R Berisio et al.
JOURNAL OF BACTERIOLOGY (2003)
Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
MI Morosini et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and β-lactams:: SMART program 2001 data
PR Hsueh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus
C Seral et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages
C Seral et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacy and tolerability of 5-day, once-daily telithromycin compared with 10-day, twice-daily clarithromycin for the treatment of group A beta-hemolytic streptococcal tonsillitis/pharyngitis: A multicenter, randomized, double-blind, parallel-group study
J Quinn et al.
CLINICAL THERAPEUTICS (2003)
In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas
KB Waites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia
L Hagberg et al.
INFECTION (2002)
Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis
M Aubier et al.
RESPIRATORY MEDICINE (2002)
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
S Rennard et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Ketolides: the future of the macrolides?
AM Nilius et al.
CURRENT OPINION IN PHARMACOLOGY (2002)
Chronic bronchitis among French adults:: high prevalence and underdiagnosis
GJ Huchon et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis
FJ Schmitz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Efficacy and tolerability of once-daily therapy with telithromycin for 5 or 10 days for the treatment of acute maxillary sinusitis
K Roos et al.
CHEMOTHERAPY (2002)
Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae
A Canu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparison of in vitro activities of ABT-773 and telithromycin against macrolide-susceptible and -resistant streptococci and staphylococci
VD Shortridge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens
ZK Ma et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S-pyogenes
K Nagai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647)
C Muller-Serieys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Telithromycin: An oral ketolide for respiratory infections
DT Bearden et al.
PHARMACOTHERAPY (2001)
In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia
PH Edelstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens
MR Hammerschlag et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
In vitro and in vivo efficacy of a novel fluoro-ketolide HMR 3562 against enterococci
M Guitton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Lung concentrations of telithromycin after oral dosing
OA Khair et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Ketolides - telithromycin, an example of a new class of antibacterial agents
A Bryskier
CLINICAL MICROBIOLOGY AND INFECTION (2000)
In vitro activity of ketolides telithromycin and HMR 3004 against Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility
E Giovanetti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils
D Vazifeh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
